The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity.
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: emboli capturing guidewire device combined with stent
- First Posted Date
- 2005-12-12
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00264043
- Locations
- 🇩🇪
Herzzentrum Siegburg GMBH, Siegburg, Germany
CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2005-10-28
- Last Posted Date
- 2007-04-04
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 2070
- Registration Number
- NCT00245401
A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.
Phase 2
Completed
- Conditions
- Renal Artery Stenosis
- Interventions
- Device: Sirolimus-eluting Palmaz Genesis peripheral stent
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 105
- Registration Number
- NCT00235157
- Locations
- 🇫🇷
Hopital Européen Georges Pompidou, Paris, France
🇩🇪Universitätskliniken Köln, Köln, Germany
🇳🇱Erasmus MC Rotterdam, Rotterdam, Netherlands
The Arterial Revascularization Therapies Study Part II.
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: drug-eluting stent
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2009-05-05
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 607
- Registration Number
- NCT00235170
- Locations
- 🇳🇱
Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands
Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA)
Phase 1
Completed
- Conditions
- Abdominal Aortic Aneurysm
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2005-12-09
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 29
- Registration Number
- NCT00235118
- Locations
- 🇺🇸
Mt. Sinai Hospital, New York, New York, United States
The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: PCI
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2008-09-16
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00235066
- Locations
- 🇨🇭
University Hospital, Swiss Cardiovascular CenterBern, Bern, Switzerland
The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: sirolimus-coated Bx Velocity stentDevice: uncoated Bx Velocity stent
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2009-05-11
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 353
- Registration Number
- NCT00235144
- Locations
- 🇩🇪
Herzkatheterlabor und Praxisklinik, Hamburg, Germany
🇩🇪Med. Klinik und Poliklinik, Münster, Germany
The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2007-04-27
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 1335
- Registration Number
- NCT00235092
- Locations
- 🇫🇷
Institut Hospitalier Jacques Cartier, Massy, France
The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent
Phase 4
Completed
- Conditions
- Arterial Occlusive Diseases
- Interventions
- Device: Smart StentDevice: Luminexx Stent
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT00235131
- Locations
- 🇩🇪
Gemeinschaftspraxis füsar Radiologische Diagnostik& Zentrum für Minimal Invasite Therapie am Jüdischen Krankenhaus Berlin, Berlin, Germany
🇩🇪Universitat Leipzig Herzzentrum Abt. Für Klinische u. Intervent. Angiologie, Leipzig, Germany
A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: drug eluting-stentDevice: drug-eluting stent
- First Posted Date
- 2005-10-07
- Last Posted Date
- 2008-04-30
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 86
- Registration Number
- NCT00234455
- Locations
- 🇮🇹
Centre Cuore Columbus, Milano, Italy